Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,854 | -$9,742 | -$6,671 | -$33,511 |
| Dep. & Amort. | $584 | $559 | $491 | $563 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $504 | $487 | $549 |
| Change in WC | $484 | -$478 | -$1,044 | -$1,159 |
| Other Non-Cash | $5,284 | $2,878 | $879 | $28,204 |
| Operating Cash Flow | -$4,502 | -$6,279 | -$5,858 | -$5,354 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,050 | -$349 | -$307 | -$214 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $4 |
| Investing Cash Flow | -$1,050 | -$349 | -$307 | -$210 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$120 | -$114 | -$98 | -$82 |
| Stock Issued | $0 | $0 | $29,143 | $11,989 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$487 | -$1,070 |
| Financing Cash Flow | -$120 | -$114 | $28,558 | $10,837 |
| Forex Effect | -$105 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,777 | -$6,742 | $22,393 | $5,273 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,987 | $32,729 | $10,336 | $5,063 |
| End Cash | $20,210 | $25,987 | $32,729 | $10,336 |
| Free Cash Flow | -$5,552 | -$6,628 | -$6,165 | -$5,568 |